Celia Oreja-Guevara, EAN 2020 – Regional Findings From The Phase 3 PREVENT Study in NMOSD

(5:35)

Celia Oreja-Guevara, EAN 2018 – MS in the 21st Century international unmet needs survey

(5:34)

EAN 2016 Celia Oreja Guevara Interview

(3:31)

Therapeutic options in multiple sclerosis

(4:8)

Dra. Celia Oreja en PALABRAS CON SALUD con Marina Montiel I Capítulo 14 #esclerosismultiple

(31:52)

Personalized medicine: an important step in the management of MS

(1:50)

Outcomes in newborns of mothers with MS

(1:32)

Menopause in multiple sclerosis patients

(3:18)

Migrating towards early and aggressive treatment strategies in MS

(2:24)

Entrevista a la dra. Celia Oreja sobre esclerosis múltiple

(3:25)

New recommendations on MS treatment and holistic patient care

(1:59)

Chromatic alterations in multiple sclerosis

(1:32)

Deciphering MS silent progression

(2:46)

Cognitive relapses as markers of disease progression in MS

(1:53)

The main challenges in the treatment of multiple sclerosis

(1:2)

Proactive management to reduce postpartum relapses in MS

(2:42)

Abnormalities in color vision in patients with multiple sclerosis

(1:24)

Dra. Celia Oreja-Guevara en #ÁgoraEM 2023

(2:12)

Clinical trials of BTK inhibitors in MS

(1:6)

Targeting the innate immune system with BTK inhibitors to treat progressive MS

(1:7)